Resistance treatment of melphalan/melphalan tablets

Melphalan is a chemotherapy drug commonly used to treat multiple myeloma and certain other cancers. However, as treatment progresses, some patients may develop drug resistance, which has a significant impact on the treatment effect. Therefore, treatment methods for melphalan resistance are particularly important.

Drug resistance often involves genetic and epigenetic changes in tumor cells, such as gene mutations, upregulation of drug efflux pumps, and enhancement of cell repair mechanisms. These mechanisms enable tumor cells to effectively resist the effects of melphalan. Therefore, research on the resistance mechanisms can help guide subsequent treatment strategies.

In cases of resistance, doctors often consider changing or combining other chemotherapy drugs. Tumor resistance can be overcome by using drugs with different mechanisms of action. For example, combining targeted therapies or immunotherapy may improve the overall effectiveness of treatment. In addition, targeted drugs targeting specific gene mutations can also be used as an alternative after drug resistance to target tumor cells more effectively.

Adjustment of treatment regimen and dose are also important aspects of drug resistance management. Clinicians can appropriately adjust the frequency or dosage of melphalan according to the patient's specific conditions in order to achieve better efficacy. Furthermore, tumor sensitivity to melphalan can sometimes be re-induced using an intermittent treatment strategy.

In addition, supportive care cannot be ignored in drug resistance management. For drug-resistant patients, attention needs to be paid to improving the quality of life and alleviating symptoms. Nutritional support, psychological counseling and management of side effects can help patients better survive the drug resistance period, thus laying the foundation for subsequent treatment.

Regular monitoring of tumor biomarkers and imaging changes is crucial to assess drug resistance and adjust treatment options. By obtaining the patient's latest status in a timely manner, doctors can make more accurate treatment decisions to improve the patient's survival rate and quality of life.